The cost-effectiveness analysis of single-tablet efavirenz-based regimen among HIV-1 infected adults in China
IntroductionIn 2018, the Chinese Guidelines for Diagnosis and Treatment of HIV/AIDS recommended the adoption of the efavirenz 400 mg-based TLE (tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) + efavirenz (EFV)) regimen as the primary first-line treatment for ART-naive HIV-1 infected adults in...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2025-05-01
|
| Serie: | Frontiers in Public Health |
| Soggetti: | |
| Accesso online: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1429461/full |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|